196 related articles for article (PubMed ID: 28746086)
1. HIV drug resistance in infants increases with changing prevention of mother-to-child transmission regimens.
Poppe LK; Chunda-Liyoka C; Kwon EH; Gondwe C; West JT; Kankasa C; Ndongmo CB; Wood C
AIDS; 2017 Aug; 31(13):1885-1889. PubMed ID: 28746086
[TBL] [Abstract][Full Text] [Related]
2. High nonnucleoside reverse transcriptase inhibitor resistance levels in HIV-1-infected Zambian mother-infant pairs.
Bennett SJ; Chunda-Liyoka C; Poppe LK; Meinders K; Chileshe C; West JT; Wood C
AIDS; 2020 Oct; 34(12):1833-1842. PubMed ID: 32889853
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of HIV-1 drug resistance amongst newly diagnosed HIV-infected infants age 4-8 weeks, enrolled in three nationally representative PMTCT effectiveness surveys, South Africa: 2010, 2011-12 and 2012-13.
Hunt GM; Ledwaba J; Salimo A; Kalimashe M; Dinh TH; Jackson D; Sherman G; Puren A; Ngandu NK; Lombard C; Morris L; Goga A
BMC Infect Dis; 2019 Sep; 19(Suppl 1):787. PubMed ID: 31526373
[TBL] [Abstract][Full Text] [Related]
4. HIV Resistance and Prevention of Mother-to-Child Transmission Regimen in HIV-Infected Infants in Northern Tanzania.
Dow DE; Schimana W; Nyombi BM; Mmbaga BT; Shayo AM; Bartlett JA; Massambu CG; Kifaro EG; Turner EL; DeMarco T; Cai F; Cunningham CK; Buchanan AM
AIDS Res Hum Retroviruses; 2017 Nov; 33(11):1107-1113. PubMed ID: 28797181
[TBL] [Abstract][Full Text] [Related]
5. Drug resistance among newly diagnosed HIV-infected children in the era of more efficacious antiretroviral prophylaxis.
Kuhn L; Hunt G; Technau KG; Coovadia A; Ledwaba J; Pickerill S; Penazzato M; Bertagnolio S; Mellins CA; Black V; Morris L; Abrams EJ
AIDS; 2014 Jul; 28(11):1673-8. PubMed ID: 24785949
[TBL] [Abstract][Full Text] [Related]
6. HIV Drug Resistance Among Children Initiating First-Line Antiretroviral Treatment in Uganda.
Kityo C; Sigaloff KC; Sonia Boender T; Kaudha E; Kayiwa J; Musiime V; Mukuye A; Kiconco M; Nankya I; Nakatudde-Katumba L; Calis JC; Rinke de Wit TF; Mugyenyi PN
AIDS Res Hum Retroviruses; 2016 Jul; 32(7):628-35. PubMed ID: 26723018
[TBL] [Abstract][Full Text] [Related]
7. Pre-treatment drug resistance and HIV-1 subtypes in infants from Argentina with and without exposure to antiretroviral drugs for prevention of mother-to-child transmission.
Aulicino PC; Zapiola I; Kademian S; Valle MM; Fernandez Giuliano S; Toro R; Barbas G; Cañizal AM; Mayon P; Golemba MD; Ortiz de Zarate M; Corazza MS; Cudola A; Mecikovsky D; Bologna R; Mangano A; Sen L
J Antimicrob Chemother; 2019 Mar; 74(3):722-730. PubMed ID: 30517632
[TBL] [Abstract][Full Text] [Related]
8. Slower clearance of nevirapine resistant virus in infants failing extended nevirapine prophylaxis for prevention of mother-to-child HIV transmission.
Persaud D; Bedri A; Ziemniak C; Moorthy A; Gudetta B; Abashawl A; Mengistu Y; Omer SB; Isehak A; Kumbi S; Adamu R; Lulseged S; Ashworth R; Hassen E; Ruff A;
AIDS Res Hum Retroviruses; 2011 Aug; 27(8):823-9. PubMed ID: 21241214
[TBL] [Abstract][Full Text] [Related]
9. Resistance Mutation Patterns among HIV-1-Infected Children and Features of the Program for Prevention of Mother-to-Child Transmission in Vietnam's Central Highlands and Southern Regions, 2017-2021.
Thu HHK; Schemelev AN; Ostankova YV; Reingardt DE; Davydenko VS; Tuong Vi N; Ngoc Tu L; Tran T; Thi Xuan Lien T; Semenov AV; Totolian AA
Viruses; 2024 Apr; 16(5):. PubMed ID: 38793578
[TBL] [Abstract][Full Text] [Related]
10. High Prevalence of HIV Drug Resistance Among Newly Diagnosed Infants Aged <18 Months: Results From a Nationwide Surveillance in Nigeria.
Inzaule SC; Osi SJ; Akinbiyi G; Emeka A; Khamofu H; Mpazanje R; Ilesanmi O; Ndembi N; Odafe S; Sigaloff KCE; Rinke de Wit TF; Akanmu S
J Acquir Immune Defic Syndr; 2018 Jan; 77(1):e1-e7. PubMed ID: 28961680
[TBL] [Abstract][Full Text] [Related]
11. Human Immunodeficiency Virus (HIV) Drug Resistance in African Infants and Young Children Newly Diagnosed With HIV: A Multicountry Analysis.
Jordan MR; Penazzato M; Cournil A; Vubil A; Jani I; Hunt G; Carmona S; Maphalala G; Mthethwa N; Watera C; Kaleebu P; Musanhu CC; Mtapuri-Zinyowera S; Dzangare J; Peeters M; Yang C; Parkin N; Bertagnolio S
Clin Infect Dis; 2017 Nov; 65(12):2018-2025. PubMed ID: 29020335
[TBL] [Abstract][Full Text] [Related]
12. Emergence of NNRTI drug resistance mutations after single-dose nevirapine exposure in HIV type 1 subtype C-infected infants in India.
Kurle SN; Gangakhedkar RR; Sen S; Hayatnagarkar SS; Tripathy SP; Paranjape RS
AIDS Res Hum Retroviruses; 2007 May; 23(5):682-5. PubMed ID: 17530993
[TBL] [Abstract][Full Text] [Related]
13. Persistence of HIV drug resistance among South African children given nevirapine to prevent mother-to-child-transmission.
Kanthula R; Rossouw TM; Feucht UD; van Dyk G; Beck IA; Silverman R; Olson S; Salyer C; Cassol S; Frenkel LM
AIDS; 2017 May; 31(8):1143-1148. PubMed ID: 28301421
[TBL] [Abstract][Full Text] [Related]
14. Next generation sequencing improves detection of drug resistance mutations in infants after PMTCT failure.
Fisher RG; Smith DM; Murrell B; Slabbert R; Kirby BM; Edson C; Cotton MF; Haubrich RH; Kosakovsky Pond SL; Van Zyl GU
J Clin Virol; 2015 Jan; 62():48-53. PubMed ID: 25542470
[TBL] [Abstract][Full Text] [Related]
15. High Rates of Drug Resistance Among Newly Diagnosed HIV-infected Children in the National Prevention of Mother-to-child Transmission Program in Togo.
Salou M; Butel C; Konou AA; Ekouevi DK; Vidal N; Dossim S; Lawson-Evi K; Nyasenu YT; Singo-Tokofaï A; d'Almeida S; Tchama R; Delaporte E; Prince-David M; Peeters M; Dagnra AY
Pediatr Infect Dis J; 2016 Aug; 35(8):879-85. PubMed ID: 27167115
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of drug-resistance mutations and non-subtype B strains among HIV-infected infants from New York State.
Karchava M; Pulver W; Smith L; Philpott S; Sullivan TJ; Wethers J; Parker MM
J Acquir Immune Defic Syndr; 2006 Aug; 42(5):614-9. PubMed ID: 16868498
[TBL] [Abstract][Full Text] [Related]
17. Emergence of HIV-1 drug resistance mutations in mothers on treatment with a history of prophylaxis in Ghana.
Martin-Odoom A; Brown CA; Odoom JK; Bonney EY; Ntim NAA; Delgado E; Lartey M; Sagoe KW; Adiku T; Ampofo WK
Virol J; 2018 Sep; 15(1):143. PubMed ID: 30223845
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 drug mutations in children from northern Tanzania.
Shao ER; Kifaro EG; Chilumba IB; Nyombi BM; Moyo S; Gaseitsiwe S; Musonda R; Johannessen A; Kibiki G; Essex M
J Antimicrob Chemother; 2014 Jul; 69(7):1928-32. PubMed ID: 24729604
[TBL] [Abstract][Full Text] [Related]
19. Persistence of genotypic resistance to nelfinavir among women exposed to prophylactic antiretroviral therapy during pregnancy.
Kakehasi FM; Tupinambás U; Cleto S; Aleixo A; Lin E; Melo VH; Aguiar RA; Pinto JA
AIDS Res Hum Retroviruses; 2007 Dec; 23(12):1515-20. PubMed ID: 18160009
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 drug resistance emergence among breastfeeding infants born to HIV-infected mothers during a single-arm trial of triple-antiretroviral prophylaxis for prevention of mother-to-child transmission: a secondary analysis.
Zeh C; Weidle PJ; Nafisa L; Lwamba HM; Okonji J; Anyango E; Bondo P; Masaba R; Fowler MG; Nkengasong JN; Thigpen MC; Thomas T
PLoS Med; 2011 Mar; 8(3):e1000430. PubMed ID: 21468304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
